Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC: Figure 1-Reference-Cited by-同舟云学术

Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC: Figure 1

Published:2015-05-06 Issue:40 Volume:36 Page:2677-2680
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Rosano Giuseppe M.C.,Lewis Basil,Agewall Stefan,Wassmann Sven,Vitale Cristiana,Schmidt Harald,Drexel Heinz,Patak Atul,Torp-Pedersen Christian,Kjeldsen Keld Per,Tamargo Juan

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/40/2677/6732417/ehv161.pdf

Reference19 articles.

1. Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology

2. Sex Differences in Pharmacokinetics and Pharmacodynamics

3. Gender Aspects in Cardiovascular Pharmacology

4. Sex Differences in Pharmacokinetics and Pharmacodynamics

5. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

2. Sex-specific considerations in cardiovascular drug therapy;Canadian Journal of Physiology and Pharmacology;2024-09-01

3. HFpEF and sex: understanding the role of sex differences;CAN J PHYSIOL PHARM;2024

4. HFpEF and sex: understanding the role of sex differences;Canadian Journal of Physiology and Pharmacology;2024-08-01

5. Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure;International Journal of Cardiology;2024-08